According to Cerus's latest financial reports the company's current revenue (TTM) is $0.15 B. In 2022 the company made a revenue of $0.16 B an increase over the years 2021 revenue that were of $0.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.15 B | -3.51% |
2022 | $0.16 B | 23.83% |
2021 | $0.13 B | 42.36% |
2020 | $91.92 M | 23.14% |
2019 | $74.64 M | 22.56% |
2018 | $60.9 M | 39.8% |
2017 | $43.56 M | 17.17% |
2016 | $37.18 M | 8.65% |
2015 | $34.22 M | -6.02% |
2014 | $36.41 M | -8.17% |
2013 | $39.65 M | 8.34% |
2012 | $36.6 M | 10.77% |
2011 | $33.04 M | 42.99% |
2010 | $23.1 M | 28.51% |
2009 | $17.98 M | 8.94% |
2008 | $16.5 M | 56.91% |
2007 | $10.52 M | -70.43% |
2006 | $35.58 M | 45.99% |
2005 | $24.37 M | 75.19% |
2004 | $13.91 M | 43.93% |
2003 | $9.66 M | 13.84% |
2002 | $8.49 M | 87.21% |
2001 | $4.53 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $14.24 B | 9,006.78% | ๐บ๐ธ USA |
Utah Medical Products UTMD | $51.46 M | -67.09% | ๐บ๐ธ USA |
Haemonetics HAE | $1.27 B | 712.31% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | $0.06 M | -99.96% | ๐บ๐ธ USA |